These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23263854)

  • 21. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J; Mørk A; Brennum LT; Sager TN
    Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization.
    Shen YQ; Hebert G; Su Y; Moze E; Neveu PJ; Li KS
    Brain Res; 2005 May; 1045(1-2):31-7. PubMed ID: 15910760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease.
    Barbiero JK; Santiago RM; Lima MM; Ariza D; Morais LH; Andreatini R; Vital MA
    Behav Brain Res; 2011 Jan; 216(1):186-92. PubMed ID: 20688106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
    Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum.
    Fabre E; Monserrat J; Herrero A; Barja G; Leret ML
    J Physiol Biochem; 1999 Dec; 55(4):325-31. PubMed ID: 10731084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
    Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
    Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
    Dluzen DE
    Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
    Morissette M; Jourdain S; Al Sweidi S; Menniti FS; Ramirez AD; Di Paolo T
    Neuropharmacology; 2007 Jun; 52(7):1509-20. PubMed ID: 17420033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
    Muthian G; Mackey V; King J; Charlton CG
    Neuroscience; 2010 Sep; 169(3):1085-93. PubMed ID: 20540993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protective effect of nicotinamide in a mouse Parkinson's disease model].
    Xu J; Xu SQ; Liang J; Lu Y; Luo JH; Jin JH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):146-52. PubMed ID: 22499510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL; Hashim A; Lajtha A; Sershen H
    J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease.
    Kurosaki R; Muramatsu Y; Kato H; Araki T
    Pharmacol Biochem Behav; 2004 May; 78(1):143-53. PubMed ID: 15159144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
    Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A
    Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
    McGrew DM; Irwin I; Langston JW
    Neurotoxicology; 2000 Jun; 21(3):309-12. PubMed ID: 10894120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.